Quotes: MENA   Enter Symbol: NewsLetter: Search: advanced

Experts in Africa cautious on potential malaria vaccine  Join our daily free Newsletter

MENAFN - AFP - 08/10/2013
No. of Ratings : 0
Add to Mixx!

(MENAFN - AFP) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday to news that the first vaccine against the killer disease may soon reach the market.

GlaxoSmithKline said it was seeking approval for a prototype vaccine that reduced the risk of malaria by almost half among children aged between five and 17 months, and by around a quarter among infants aged between six and 12 weeks.

"This is the first vaccine against malaria," Sophie Biernaux, a malaria vaccine leader at GSK, told AFP in Durban.

If the British drugmaker's application is successful, the vaccine could be rolled out within two years.

The mosquito-borne disease kills an estimated 660,000 people each year, 90 percent of them in Africa, with the majority being children under five.

"This is great hope for Africa," Nilton Saraivo, a manager of Angola's national anti-malaria programme, told AFP.

But others were more cautious.

In Gabon, one of the countries where clinical trials were conducted, researcher Bertrand Lell said the vaccine's efficacy "is not very large" compared to vaccines such as the one against polio.

"But given the prevalence of malaria in Africa, you can imagine the impact it will have on people if the mortality rate is down 50 percent," said Lell, of the Lambarene Centre for Medical Research.

In the Democratic Republic of Congo -- which has the world's second-highest malaria death rate after Nigeria -- SANRU, an organisation that distributes mosquito nets to fight malaria, said it was too early to declare victory.

It noted that the vaccine did not offer a complete shield, although trials -- including assessment of a booster shot -- are ongoing.

"This is good news as long as the vaccine shows a required level of efficacy," said John Gikapa, technical advisor to SANRU.

The research was carried out at 11 centres in seven African countries, covering more than 15,000 infants and children.

GSK said it would now file an application to the European Medicines Agency (EMA) under a process aimed at marketing new drugs for poorer countries.

The European medications watchdog will then give a "scientific opinion" on the vaccine's safety and efficacy.

This opens the way for it to be considered by the World Health Organisation (WHO), which in turn can fast-track its licensing in individual countries in Africa.

The vaccine -- called RTS,S -- is a frontrunner in the race to develop the first immunisation for malaria.

The results for the Phase III trial were unveiled Tuesday at a conference in South Africa.

They are sure to raise as many questions as answers.

As well as offering less protection for very small children, the vaccine's effectiveness declined over time, data showed.

"There are a number of possible hypotheses for these differences" in effectiveness, said Lucas Otieno of the Kenya Medical Research Institute, one of the principal investigators in the trial.

The theories include possible interference with the vaccine by maternal antibodies and the impact of other vaccines administered around the same time, he said.

'Any progress welcome'

Experts are also wary about the logistics of administering the vaccine in Africa, where the people most at risk often live in poverty-stricken and difficult-to-access places.

Just getting drugs to where they are needed can be a headache, requiring proper handling in hot, humid environments and secure storage in countries where theft or corruption may be rampant.

"Any progress on fighting malaria is very welcome, and this vaccine could be another important weapon in our armoury," said Martin de Smet, a malaria specialist with Doctors Without Borders (MSF).

"Delivering injection-based vaccines in the kind of environments where malaria is prominent is also hugely challenging -- even for treatments that are 100-percent effective," he said.

"Locations are traditionally remote, with people having to walk for days to get to a health facility, and often require refrigeration."

GSK said if it gets the green light, the vaccine would probably be distributed through agencies such as the United Nations Children's Fund and the GAVI Alliance, a public-private health partnership.

The price would cover the cost of manufacturing plus a margin of five percent which would be ploughed into research for next-generation vaccines, a GSK spokesman said.



  MENA News Headlines
 Dec 1 2015 - Opec oil output increases in Nov, led by Iraq, SaudiMENAFN
(MENAFN) Opec oil output grew in Nov compared with the previous month, led by a rebound in Iraqi exports.Moreover; Opec supply increased in Nov to 31.77mn containers per day, from 31.64mn in ...

 Dec 1 2015 - Etihad Airways enhances presence in East Africa with new service between Dar Es Salaam and Abu DhabiEmirates News Agency (WAM)
(MENAFN - Emirates News Agency (WAM)) ABU DHABI 1st December 2015 (WAM) --- Etihad Airways the national airline of the United Arab Emirates today enhanced its presence in East Africa with the ...

 Dec 1 2015 - Hazza bin Zayed statement on national day UAENationalDay44Emirates News Agency (WAM)
(MENAFN - Emirates News Agency (WAM)) ABU DHABI 1st December 2015 (WAM)--H.H. Sheikh Hazza bin Zayed Al Nahyan National Security Advisor has paid a glowing tribute to the founding fathers who ...

 Dec 1 2015 - Rising foreign investment in Dubai realty to ensure stability in real estate market: H Holding EnterpriseEmirates News Agency (WAM)
(MENAFN - Emirates News Agency (WAM)) DUBAI 1st December 2015 (WAM) --- The growing number of foreign investors in Dubai property will lead to more stability in the real estate market according ...

 Dec 1 2015 - Mansour bin Zayed's statement on national day UAENationalDay44Emirates News Agency (WAM)
(MENAFN - Emirates News Agency (WAM)) ABU DHABI 1st December 2015 (WAM)H.H. Sheikh Mansour bin Zayed Al Nahyan Deputy Prime Minister and Minister of Presidential Affairs has extended his ...

 Dec 1 2015 - ST Topping Pattern Begins to Emerge in USDOLLARDailyFX
(MENAFN - DailyFX) On a fundamental basis, we were already concerned about the viability of a USDOLLAR Index bull flag breakout given the wave of impending "high" level event risk at the end of this ...

 Dec 1 2015 - Saudi- Competition Council launches awareness caign to combat collusion in public tendersSaudi Press Agency
(MENAFN - Saudi Press Agency) Riyadh 19 Safar 1437 AH December 1 2015 SPA -- The Competition Council has launched its 5th awareness campaign for the second year of publication of competition culture ...

 Dec 1 2015 - Competition Council launches awareness caign to combat collusion in public tenders 2 RiyadhSaudi Press Agency
(MENAFN - Saudi Press Agency) The campaign also aims to deliver the message of the Council using a variety of methods of press and electronic ads and the design and production of audio-visual films ...

 Dec 1 2015 - Kuwait Stock Exchange ends session with mixed boardsSaudi Press Agency
(MENAFN - Saudi Press Agency) KUWAIT Safar 19 1437 December 01 2015 SPA -- Kuwait Stock Exchange (KSE) ended its session Tuesday in a mixed board with the price index up by 0.98 points to reach 5803 ...

 Dec 1 2015 - Muscat Securities Market Gains 9 PointsSaudi Press Agency
(MENAFN - Saudi Press Agency) Muscat Safar 19 1437 December 01 2015 SPA -- Muscat Securities Market (MSM) general index (30) today added (9.9) points comprising a rise by (0.18%) to close at ...




Click to Apply


Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  

Middle East North Africa - Financial Network

Main News
News By Industry
News By Country

Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices


Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks

Saudi Arabia 

Economic Calendar
Financial Glossary

Financial Calculators

RSS Feeds [XML]

Corporate Monitor


Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters

© 2014 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help